Microarray screening for novel preeclampsia biomarker candidates

Fetal Diagnosis and Therapy

Volumn 31, Issue 3, 2012, Pages 147-153

  Lapaire, Olav ^a   Grill, Simon ^a   Lalevee, Sebastien ^a   Kolla, Varaprasad ^a   HÖsli, Irene ^a   Hahn, Sinuhe ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Biomarkers; Preeclampsia; Pregnancy; Screening

Indexed keywords

ADAM METALLOPEPTIDASE DOMAIN 2; ADAM PROTEIN; BINDING PROTEIN; CD97 ANTIGEN; CHEMOKINE RECEPTOR CX3CR1; CHORIONIC GONADOTROPIN BETA SUBUNIT; CORTICOTROPIN RELEASING HORMONE BINDING PROTEIN; HTRA SERINE PEPTIDASE; INHIBIN B; LUTEINIZING HORMONE BETA SUBUNIT; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MATRIX METALLOPROTEINASE 19; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SERINE PROTEINASE; TRANSCRIPTION FACTOR FOSB; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; BLOOD ANALYSIS; CASE CONTROL STUDY; CESAREAN SECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC SCREENING; HUMAN; HUMAN TISSUE; MATERNAL BLOOD; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

ADULT; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CHORIONIC VILLI; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC MARKERS; HUMANS; LUTEINIZING HORMONE, BETA SUBUNIT; NADPH OXIDASE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRE-ECLAMPSIA; PREGNANCY; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SERINE ENDOPEPTIDASES; SWITZERLAND; YOUNG ADULT;

EID: 84860318386     PISSN: 10153837     EISSN: 14219964     Source Type: Journal    
DOI: 10.1159/000337325     Document Type: Article

References (33)

1. Duley L: The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009; 33: 130-137.
2. Grill S, Rusterholz C, Zanetti-Dallenbach R, Tercanli S, Holzgreve W, Hahn S, Lapaire O: Potential markers of preeclampsia-a review. Reprod Biol Endocrinol 2009; 7: 70-84.
3. Redman CW, Sargent IL: Immunology of pre-eclampsia. Am J Reprod Immunol 2010; 63: 534-543.
4. Staff AC, Dechend R, Pijnenborg R: Learning from the placenta: acute atherosis and vascular remodeling in preeclampsia-novel aspects for atherosclerosis and future cardiovascular health. Hypertension 2010; 56: 1026-1034.
5. Bujold E, Morency AM, Roberge S, Lacasse Y, Forest JC, Giguere Y: Acetylsalicylic acid for the prevention of preeclampsia and intrauterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis. J Obstet Gynaecol Can 2009; 31: 818-826.
6. Alfonso H: Preventing preeclampsia: the evidence on nutrients. Nurs Womens Health 2009; 13: 419-421.
7. Barton JR, Sibai BM: Prediction and prevention of recurrent preeclampsia. Obstet Gynecol 2008; 112: 359-372.
8. Verlohren S, Galindo A, Schlembach D, Zeisler H, Herraiz I, Moertl MG, Pape J, Dudenhausen JW, Denk B, Stepan H: An automated method for the determination of the sFlt-1/PlGF in the assessment of preeclampsia. Am J Obstet Gynecol 2010; 202: 161.e1-161.e11.
9. Shennan AH, Redman C, Cooper C, Milne F: Are most maternal deaths from pre-eclampsia avoidable? Lancet 2011, E-pub ahead of print.
10. Gack S, Marme A, Marme F, Wrobel G, Vonderstrass B, Bastert G, Lichter P, Angel P, Schorpp-Kistner M: Preeclampsia: increased expression of soluble ADAM 12. J Mol Med 2005; 83: 887-896. (Pubitemid 41598689)
11. Hansson SR, Chen Y, Brodszki J, Chen M, Hernandez-Andrade E, Inman JM, Kozhich OA, Larsson I, Marsal K, Medstrand P, Xiang CC, Brownstein MJ: Gene expression profiling of human placentas from preeclamptic and normotensive pregnancies. Mol Hum Reprod 2006; 12: 169-179.
12. Heikkila A, Tuomisto T, Hakkinen SK, Keski-Nisula L, Heinonen S, Yla-Herttuala S: Tumor suppressor and growth regulatory genes are overexpressed in severe early-onset preeclampsia-an array study on case-specific human preeclamptic placental tissue. Acta Obstet Gynecol Scand 2005; 84: 679-689. (Pubitemid 40917393)
13. Tsoi SC, Cale JM, Bird IM, Kay HH: cDNA microarray analysis of gene expression profiles in human placenta: up-regulation of the transcript encoding muscle subunit of glycogen phosphorylase in preeclampsia. J Soc Gynecol Investig 2003; 10: 496-502. (Pubitemid 37510009)
14. Nishizawa H, Pryor-Koishi K, Kato T, Kowa H, Kurahashi H, Udagawa Y: Microarray analysis of differentially expressed fetal genes in placental tissue derived from early and late onset severe pre-eclampsia. Placenta 2007; 28: 487-497. (Pubitemid 46593762)
15. Pang ZJ, Xing FQ: Comparative profiling of metabolism-related gene expression in preeclamptic and normal pregnancies. Arch Gynecol Obstet 2004; 269: 91-95.
16. Reimer T, Koczan D, Gerber B, Richter D, Thiesen HJ, Friese K: Microarray analysis of differentially expressed genes in placental tissue of pre-eclampsia: up-regulation of obesity-related genes. Mol Hum Reprod 2002; 8: 674-680. (Pubitemid 34752929)
17. Soleymanlou N, Jurisica I, Nevo O, Ietta F, Zhang X, Zamudio S, Post M, Caniggia I: Molecular evidence of placental hypoxia in preeclampsia. J Clin Endocrinol Metab 2005; 90: 4299-4308. (Pubitemid 41058212)
18. Zhou R, Zhu Q, Wang Y, Ren Y, Zhang L, Zhou Y: Genomewide oligonucleotide microarray analysis on placentae of preeclamptic pregnancies. Gynecol Obstet Invest 2006; 62: 108-114. (Pubitemid 44200491)
19. Enquobahrie DA, Meller M, Rice K, Psaty BM, Siscovick DS, Williams MA: Differential placental gene expression in preeclampsia. Am J Obstet Gynecol 2008; 199: 566.e1-566.e11.
20. Pang ZJ, Xing FQ: Comparative study on the expression of cytokine-receptor genes in normal and preeclamptic human placentas using DNA microarrays. J Perinat Med 2003; 31: 153-162.
21. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC, Gaasterland T, Glenisson P, Holstege FC, Kim IF, Markowitz V, Matese JC, Parkinson H, Robinson A, Sarkans U, Schulze-Kremer S, Stewart J, Taylor R, Vilo J, Vingron M: Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 2001; 29: 365-371. (Pubitemid 34326681)
22. Rozen S, Skaletsky HJ: Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000; 132: 365-386.
23. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408. (Pubitemid 34164012)
24. Sitras V, Paulssen RH, Gronaas H, Leirvik J, Hanssen TA, Vartun A, Acharya G: Differential placental gene expression in severe preeclampsia. Placenta 2009; 30: 424-433.
25. Varkonyi T, Nagy B, Fule T, Tarca AL, Karaszi K, Schonleber J, Hupuczi P, Mihalik N, Kovalszky I, Rigo J Jr, Meiri H, Papp Z, Romero R, Than NG: Microarray profiling reveals that placental transcriptomes of early-onset HELLP syndrome and preeclampsia are similar. Placenta 2011; 32(suppl):S21-S29.
26. Kang JH, Song H, Yoon JA, Park DY, Kim SH, Lee KJ, Farina A, Cho YK, Kim YN, Park SW, Kim GJ, Shim SH, Cha DH: Preeclampsia leads to dysregulation of various signaling pathways in placenta. J Hypertens 2011; 29: 928-936.
27. Lorenzi T, Marzioni D, Giannubilo S, Quaranta A, Crescimanno C, De Luca A, Baldi A, Todros T, Tranquilli AL, Castellucci M: Expression patterns of two serine protease HtrA1 forms in human placentas complicated by preeclampsia with and without intrauterine growth restriction. Placenta 2009; 30: 35-40.
28. Marzioni D, Quaranta A, Lorenzi T, Morroni M, Crescimanno C, De Nictolis M, Toti P, Muzzonigro G, Baldi A, De Luca A, Castellucci M: Expression patterns of two serine protease HtrA1 forms in human placentas complicated by preeclampsia with and without intrauterine growth restriction. Histol Histopathol 2009; 24: 1213-1222.
29. Ago T, Kitazono T, Ooboshi H, Iyama T, Han YH, Takada J, Wakisaka M, Ibayashi S, Utsumi H, Iida M: Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation 2004; 109: 227-233. (Pubitemid 38114144)
30. Rani N, Dhingra R, Arya DS, Kalaivani M, Bhatla N, Kumar R: Role of oxidative stress markers and antioxidants in the placenta of preeclamptic patients. J Obstet Gynaecol Res 2010; 36: 1189-1194.
31. Many A, Hubel CA, Fisher SJ, Roberts JM, Zhou Y: Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia. Am J Pathol 2000; 156: 321-331. (Pubitemid 30644466)
32. Brennecke SP, Cincotta RB: Family history of pre-eclampsia as a predictor for pre-eclampsia in primigravidas. Int J Gynaecol Obstet 1998; 60: 23-27. (Pubitemid 28055272)
33. Reddy A, Zhong XY, Rusterholz C, Hahn S, Holzgreve W, Redman CW, Sargent IL: The effect of labour and placental separation on the shedding of syncytiotrophoblast microparticles, cell-free DNA and mRNA in normal pregnancy and pre-eclampsia. Placenta 2008; 29: 942-949.